BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang W, Xu Y, Zhang Y, Zhang P, Zhang Q, Zhang Z, Xu F. Metabolomics-driven identification of adenosine deaminase as therapeutic target in a mouse model of Parkinson's disease. J Neurochem 2019;150:282-95. [PMID: 31121068 DOI: 10.1111/jnc.14774] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Gonzalez-covarrubias V, Martínez-martínez E, Bosque-plata LD. The Potential of Metabolomics in Biomedical Applications. Metabolites 2022;12:194. [DOI: 10.3390/metabo12020194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
2 Fiore NJ, Ganat YM, Devkota K, Batorsky R, Lei M, Lee K, Cowen LJ, Croft G, Noggle SA, Nieland TJF, Kaplan DL. Bioengineered models of Parkinson’s disease using patient-derived dopaminergic neurons exhibit distinct biological profiles in a 3D microenvironment. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-021-04047-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wang M, Xu J, Yang N, Zhang T, Zhu H, Wang J. Insight Into the Metabolomic Characteristics of Post-Transplant Diabetes Mellitus by the Integrated LC-MS and GC-MS Approach- Preliminary Study. Front Endocrinol 2022;12:807318. [DOI: 10.3389/fendo.2021.807318] [Reference Citation Analysis]
4 Gu C, Chen Y, Chen Y, Liu CF, Zhu Z, Wang M. Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson's Disease. Front Aging Neurosci 2021;13:768156. [PMID: 34867296 DOI: 10.3389/fnagi.2021.768156] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Chang CP, Wu KC, Lin CY, Chern Y. Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases. J Biomed Sci 2021;28:70. [PMID: 34635103 DOI: 10.1186/s12929-021-00766-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Nascimento FP, Macedo-Júnior SJ, Lapa-Costa FR, Cezar-Dos-Santos F, Santos ARS. Inosine as a Tool to Understand and Treat Central Nervous System Disorders: A Neglected Actor? Front Neurosci 2021;15:703783. [PMID: 34504414 DOI: 10.3389/fnins.2021.703783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nelson KL, Voruganti VS. Purine metabolites and complex diseases: role of genes and nutrients. Curr Opin Clin Nutr Metab Care 2021;24:296-302. [PMID: 33928921 DOI: 10.1097/MCO.0000000000000764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Hou Y, Li X, Liu C, Zhang M, Zhang X, Ge S, Zhao L. Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease. Exp Gerontol 2021;150:111376. [PMID: 33905875 DOI: 10.1016/j.exger.2021.111376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Dienel GA. Stop the rot. Enzyme inactivation at brain harvest prevents artifacts: A guide for preservation of the in vivo concentrations of brain constituents. J Neurochem 2021. [PMID: 33636013 DOI: 10.1111/jnc.15293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yang T, Zhan Z, Zhang L, Zhu J, Liu Y, Zhang L, Ge J, Zhao Y, Zhang L, Dong J. Prevalence and Risk Factors for Malnutrition in Patients With Parkinson's Disease. Front Neurol 2020;11:533731. [PMID: 33362679 DOI: 10.3389/fneur.2020.533731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
11 Gątarek P, Kałużna-Czaplińska J, Pawełczyk M, Jastrzębski K, Giebułtowicz J, Głąbiński A, Bobrowska-Korczak B. LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson's Disease and Parkinsonian Syndromes Patients. Molecules 2020;25:E4959. [PMID: 33120888 DOI: 10.3390/molecules25214959] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Dienel GA. Metabolomic and Imaging Mass Spectrometric Assays of Labile Brain Metabolites: Critical Importance of Brain Harvest Procedures. Neurochem Res 2020;45:2586-606. [PMID: 32949339 DOI: 10.1007/s11064-020-03124-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Von Seggern M, Szarowicz C, Swanson M, Cavotta S, Pike ST, Lamberts JT. Purine molecules in Parkinson's disease: Analytical techniques and clinical implications. Neurochem Int 2020;139:104793. [PMID: 32650026 DOI: 10.1016/j.neuint.2020.104793] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Santoni G, Maggi F, Amantini C, Marinelli O, Nabissi M, Morelli MB. Pathophysiological Role of Transient Receptor Potential Mucolipin Channel 1 in Calcium-Mediated Stress-Induced Neurodegenerative Diseases. Front Physiol. 2020;11:251. [PMID: 32265740 DOI: 10.3389/fphys.2020.00251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]